Director of Benign Hematology Clinical Research - Icahn School of Medicine - Manhattan, NY

Mount Sinai Health SystemNew York, NY
$375,000 - $475,000Onsite

About The Position

The Division of Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai is seeking an accomplished physician-scientist to serve as Director of Benign Hematology Clinical Research. This is a distinctive leadership opportunity for an individual with a strong record in benign hematology clinical care and research to build and direct a comprehensive clinical research program addressing non-malignant blood disorders with a focus on coagulation, bleeding and thrombosis, leveraging Mount Sinai’s excellence in clinical care as an HHS-funded Hemophilia Treatment Center, and complementing existing NIH-funded clinical and translational research programs in sickle cell disease, iron disorders, myeloproliferative disorders, and graft-vs-host disease.

Requirements

  • MD or MD/PhD with current board certification/eligibility in Hematology
  • A distinguished record of clinical and translational research in benign hematology
  • Demonstrated leadership experience directing or co-directing a clinical research program, clinical trials unit, or comparable initiative
  • A strong publication record and national or international reputation in the field of non-malignant hematologic disorders
  • Experience building multidisciplinary collaborations and mentoring early-career investigators
  • Eligibility for a faculty appointment at the Icahn School of Medicine at Mount Sinai at a rank commensurate with experience

Nice To Haves

  • A sustained record of extramural funding and/or leadership in sponsored multicenter trials is desirable

Responsibilities

  • Design, launch, and oversee a robust clinical trials portfolio spanning disorders such as bleeding and clotting disorders, bone marrow failure syndromes, and other non-malignant hematologic conditions (with the exception of other funded programs such as sickle cell disease)
  • Recruit, mentor, and develop junior faculty, fellows, and research staff engaged in benign hematology research
  • Secure and manage extramural funding, including NIH, foundation, and industry-sponsored support
  • Collaborate with basic and translational scientists to advance mechanistic understanding and novel therapeutics for benign blood disorders
  • Partner with the Division's malignant hematology, oncology, and transplant programs, as well as pediatric hematology, to build cohesive, cross-cutting research initiatives
  • Maintain an active clinical practice caring for patients with benign hematologic disease
  • Contribute to the education and training of medical students, residents, and fellows
  • Represent Mount Sinai in national and international benign hematology research consortia and professional societies

Benefits

  • Comprehensive benefits package
  • Substantial institutional support for research
  • Salary and startup package will be highly competitive and commensurate with experience and academic accomplishment.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service